These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 2644008

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E, Ezetimibe Study Group.
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [Abstract] [Full Text] [Related]

  • 24. Lovastatin to prevent acute coronary events with average cholesterol levels.
    MacFarlane LL, Carek PJ.
    J Fam Pract; 1998 Aug; 47(2):91-2. PubMed ID: 9722787
    [No Abstract] [Full Text] [Related]

  • 25. [Evidence of the efficacy of hypocholesterolemic treatment in primary and secondary prevention of ischemic heart disease].
    Alvarez-Sala Walther LA, Millán Núñez-Cortés J.
    Med Clin (Barc); 2000 Aug; 114 Suppl 2():1-10. PubMed ID: 10916798
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The special cholesterol concerns of women.
    Johns Hopkins Med Lett Health After 50; 2000 Sep; 12(7):4-5. PubMed ID: 10948881
    [No Abstract] [Full Text] [Related]

  • 31. Treatable risk factors--hypercholesterolemia, smoking, and hypertension--after myocardial infarction: implications of the coronary drug project data for clinical management. Coronary Drug Project Research Group.
    Prim Care; 1980 Mar; 7(1):175-9. PubMed ID: 6992178
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. More on cholesterol.
    Kalant N.
    CMAJ; 1993 Jul 01; 149(1):17; author reply 17-8. PubMed ID: 8319149
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Benefits and risks of lowering serum cholesterol.
    Verschuren WM.
    Epidemiology; 1997 Mar 01; 8(2):120-2. PubMed ID: 9229199
    [No Abstract] [Full Text] [Related]

  • 39. [Cholesterol: how and when to treat it?].
    Masana Marín L.
    Med Clin (Barc); 1985 Oct 05; 85(10):423-5. PubMed ID: 4079497
    [No Abstract] [Full Text] [Related]

  • 40. [Current developments in prevention of coronary heart disease].
    Windler E.
    Z Arztl Fortbild (Jena); 1996 Feb 05; 90(1):7-10. PubMed ID: 8650967
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.